<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04239547</url>
  </required_header>
  <id_info>
    <org_study_id>osagir-4</org_study_id>
    <nct_id>NCT04239547</nct_id>
  </id_info>
  <brief_title>Effects of Recruitment Maneuver During Intraoperative Period</brief_title>
  <official_title>Effects of Recruitment Maneuver on Perioperative Pulmonary Complications in Hysterectomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balikesir University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Balikesir University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to observe the effect of respiratory recruitment maneuver on&#xD;
      intraoperative ventilatory parameters and postoperative pulmonary complications in patients&#xD;
      over 18 years scheduled for laparoscopic hysterectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients over 18 years who are scheduled for laparoscopic hysterectomy volunteering to&#xD;
      participate in our study will receive anesthesia induction with one of our standard general&#xD;
      anesthesia protocols. After intubation recruitment maneuver will be applied to the study&#xD;
      group. General anesthesia and mechanical ventilation will be continued and completed&#xD;
      according to our standard practice without any further intervention. Throughout the&#xD;
      intraoperative period respiratory and haemodynamic parameters including compliance, airway&#xD;
      resistance, mean arterial pressure, heart rate, pulse oxymetry, blood gas analysis, the&#xD;
      applied inhalational anesthetic agent, minimum alveolar concentration, expiratory agent&#xD;
      concentration and total agent consumption will be recorded. At the end of the operation&#xD;
      anesthesia will be terminated and patients will be transferred to postanesthesia care unit&#xD;
      (recovery unit after recovery and further discharged from to the ward when their Aldrete&#xD;
      score is &gt;8. The patients will be examined for respiratory complications on postoperative day&#xD;
      1, and will be followed up by telephone on day 5.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Actual">August 1, 2020</completion_date>
  <primary_completion_date type="Actual">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group 1, Alveolar Recruitment Maneuver+positive end expiratory pressure (PEEP) Group 2, PEEP</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>The investigator, the participant and outcomes assessor will be masked to the intervention. Only the caregiver will be aware of the group and intervention received.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>measurement of change in airway compliance</measure>
    <time_frame>T1:1minute(min)after intubationT2:5 min after Mechanical Ventilation(MV),T3:5 min after pneumoperitoneum,T4:3 min after Trendelenburg position(TP),T5:10 min after TP T6:20 min after TP T7:10 min after pneumoperitoneum deflation T8:1 min before extubation</time_frame>
    <description>the patients airway compliance will be monitorised as milliliter / centimeter of water (mL/cmH2O) continuously by the anesthesia machine and will be recorded intermittently.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>measurement of change in Airway resistance</measure>
    <time_frame>T1:1 minute after intubationT2:5 min after MV T3:5 minute after pneumoperitoneum T4:3 minute after Trendelenburg position (TP) T5:10 minutes after TP T6:20 minutes after TP T7:10 minutes after pneumoperitoneum deflation T8:1 minute before extubation</time_frame>
    <description>the patients airway compliance will be monitorised as centimeter of water/ liter/ minute (cmH2O/L/min) continuously by the anesthesia machine and will be recorded intermittently.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>measurement of change in partial oxygen pressure (PaO2)</measure>
    <time_frame>T1:1 minute after intubation T7: 10 minute after pneumoperitoneum deflation</time_frame>
    <description>Arterial blood samples will be obtained and analysed. PaO2 will be recorded from these samples.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Postoperative respiratory distress, cough, phlegm</measure>
    <time_frame>T9: 24 hours after surgery . T10: on postoperative day 5</time_frame>
    <description>Pulmonary complications including respiratory distress, cough, phlegm will be evaluated by questionnaire and recorded.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Laparoscopic Hysterectomy</condition>
  <arm_group>
    <arm_group_label>Recruitment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients classified to receive recruitment maneuver + 5 mmHg positive end-expiratory pressure after anesthesia induction and intubation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-recruitment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients classified to receive only 5 mmHg positive end-expiratory pressure after anesthesia induction and intubation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Alveolar Recruitment maneuver (ARM) +PEEP</intervention_name>
    <description>Following anesthesia induction and intubation, alveolar recruitment maneuver followed by 5 mmHg PEEP</description>
    <arm_group_label>Recruitment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PEEP</intervention_name>
    <description>Following anesthesia induction and intubation, only 5 mmHg PEEP</description>
    <arm_group_label>Non-recruitment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiology (ASA) I-II&#xD;
&#xD;
          -  &gt; 18 y&#xD;
&#xD;
          -  laparoscopic hysterectomy patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal to participate in the study&#xD;
&#xD;
          -  &lt;18 y, BMI&gt; 40&#xD;
&#xD;
          -  Patients receiving invasive MV support in the last 1 month&#xD;
&#xD;
          -  Patients who received chemotherapy or radiotherapy in the last 2 months&#xD;
&#xD;
          -  Patients with severe pulmonary disease (COPD, asthma, pulm infection, bronchiectasis)&#xD;
             (those who have previously received Non-Invasive MV, oxygen therapy or steroid therapy&#xD;
             for an acute attack)&#xD;
&#xD;
          -  Those with known severe pulmonary Hypertension&#xD;
&#xD;
          -  Intracranial tm&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Shock.&#xD;
&#xD;
          -  Neuromuscular disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Balikesir University</name>
      <address>
        <city>Balikesir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>January 16, 2020</study_first_submitted>
  <study_first_submitted_qc>January 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2020</study_first_posted>
  <last_update_submitted>November 16, 2020</last_update_submitted>
  <last_update_submitted_qc>November 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Balikesir University</investigator_affiliation>
    <investigator_full_name>Ozlem Sagir, MD</investigator_full_name>
    <investigator_title>Associated professor</investigator_title>
  </responsible_party>
  <keyword>recruitment</keyword>
  <keyword>pulmonary complication</keyword>
  <keyword>oxygenisation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

